The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
Open accessAbstract
Despite the importance of spliceosome core components in cellular processes, their roles in cancer development, including hepatocellular carcinoma (HCC), remain poorly understood. In this study, we uncover a critical role for SmD2, a core component of the spliceosome machinery, in modulating DNA damage in HCC through its impact on BRCA1/FANC cassette exons and expression. Our findings reveal that SmD2 depletion sensitizes HCC cells to PARP inhibitors, expanding the potential therapeutic targets. We also demonstrate that SmD2 acetylation by p300 leads to its degradation, while HDAC2-mediated deacetylation stabilizes SmD2. Importantly, we show that the combination of Romidepsin and Olaparib exhibits significant therapeutic potential in multiple HCC models, highlighting the promise of targeting SmD2 acetylation and HDAC2 inhibition alongside PARP inhibitors for HCC treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The connection between SmD2 and drug resistance is found in the data showing PARP inhibitors as ineffective against HCC on their own, but effective against i) SmD2 KO HCC cells and ii) when combined with HDAC2 inhibitor romidepsin [118].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The connection between SmD2 and drug resistance is found in the data showing PARP inhibitors as ineffective against HCC on their own, but effective against i) SmD2 KO HCC cells and ii) when combined with HDAC2 inhibitor romidepsin [118].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [118]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SmD2 becomes acetylated on K8 by p300, which contributes to an increase in ubiquitination and a decrease in stability (Figure 6D) [118].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [118]
The cited source says what the claim attributes to it.
In the citing paper
“The connection between SmD2 and drug resistance is found in the data showing PARP inhibitors as ineffective against HCC on their own, but effective against i) SmD2 KO HCC cells and ii) when combined with HDAC2 inhibitor romidepsin [118].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [118]
The cited source says what the claim attributes to it.
In the citing paper
“Romidepsin also enhanced the effectiveness of PARP inhibitors in HCC by modulating the acetylation-mediated degradation of spliceosome component SmD2 [118].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [118]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
KEGG for linking genomes to life and the environment
Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., Katayama, T., Kawashima, S., Okuda, S., Tokimatsu, T., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm882 · Cited by 6,782
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Cited by
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond
Minisini, M., Mascaro, M., & Brancolini, C. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.103 · Cited by 24
Zhu, Z., Wu, X., Hu, Y., Bian, X., Wang, Y., & Zhu, Q. (2025) · MedComm · doi:10.1002/mco2.70545 · Cited by 23
Sadia, K., Castagna, A., Udali, S., Ambrosani, F., Pattini, P., Beri, R., Argentino, G., Masutti, M., Moruzzi, S., & Friso, S. (2025) · Cells · doi:10.3390/cells14171337 · Cited by 22
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Zhao, D., Mo, Z., Zhang, T., Cai, X., Yang, Z., Chen, D., Zhao, J., Li, Y., Zhou, F., Li, Z., et al. (2026) · Science Advances · doi:10.1126/sciadv.ady5324 · Cited by 18
Self-citation
Metadata
- Authors
- Sun, L., Liu, Y., Guo, X., Cui, T., Wu, C., Tao, J., Cheng, C., Chu, Q., Ji, C., Li, X., Guo, H., Liang, S., Zhou, H., Zhou, S., Ma, K., Zhang, N., Wang, J., Liu, Y., & Liu, L.
- Affiliations
- University of Science and Technology of China (CN)
- Corresponding author
- Wang, Jiabei
- Venue
- Nature Communications
- Published
- 2024-06-18
- Volume
- 15
- Issue
- 1
- Pages
- 5209-5209
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC11189467
- OpenAlex
- W4399766604
- Cited by
- 18
- References
- 75
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 2
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (U19A2008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- hepatocellular carcinoma, spliceosome, protein acetylation, P300, HDAC2, DNA damage response, PARP inhibitors, olaparib, romidepsin, protein stability, combination therapy
- MeSH terms
- Poly(ADP-ribose) Polymerase Inhibitors, Acetylation, Animals, DNA Damage, Exons, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Phthalazines, Piperazines, Gene Expression Regulation, Neoplastic, Spliceosomes, BRCA1 Protein, Cell Line, Tumor, Depsipeptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. https://app.cochat.ai/papers/10.1038/s41467-024-49573-7
- The paper
- Sun, L., Liu, Y., Guo, X., Cui, T., Wu, C., Tao, J., Cheng, C., Chu, Q., Ji, C., Li, X., Guo, H., Liang, S., Zhou, H., Zhou, S., Ma, K., Zhang, N., Wang, J., Liu, Y., & Liu, L. (2024). Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nature Communications. https://doi.org/10.1038/s41467-024-49573-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.